跳至主要内容
临床试验/ACTRN12612000689875
ACTRN12612000689875尚未招募未知

Prospective detection of vestibular abnormalities resulting from the administration of Gentamicin and documentation of their subsequent recovery.

Capital and Coast District Health Board (CCDHB)0 个研究点目标入组 500 人开始时间: 2012年6月27日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
500

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Participants must: be able to give consent prior to or while being treated at Wellington Hospital or Hutt Valley Hospital. The only inclusion criteria at day 1 will be treatment or pending treatment with IV Gentamicin within 24 hrs of measurement of the VOR gain.

排除标准

  • Patients so unwell that they do not wish to have their head moved or who decline testing or who are regarded by the examiner as being too ill to adequately co-operate.

研究者

发起方
Capital and Coast District Health Board (CCDHB)

相似试验

Prospective study - detecting incidence and recovery... | 临床试验